1. Cost-Effectiveness Analysis of Treatments for Metastatic Pancreatic Cancer Based on Prodige and MPACT Trials. Issue 3 (May 2016) Authors: Zhou, Jing; Zhao, Rongce; Wen, Feng; Zhang, Pengfei; Wu, Yifan; Tang, Ruilei; Chen, Hongdou; Zhang, Jian; Li, Qiu Journal: Tumori Issue: Volume 102:Issue 3(2016) Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma. Issue 7 (July 2015) Authors: Zhang, Pengfei; Yang, Yu; Wen, Feng; He, Xiaofeng; Tang, Ruilei; Du, Zedong; Zhou, Jing; Zhang, Jian; Li, Qiu Journal: European journal of gastroenterology & hepatology Issue: Volume 27:Issue 7(2015:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial. Issue 27 (July 2016) Authors: Zhou, Jing; Zhao, Rongce; Wen, Feng; Zhang, Pengfei; Tang, Ruilei; Chen, Hongdou; Zhang, Jian; Li, Qiu Editors: G Koniaris., Leonidas Journal: Medicine Issue: Volume 95:Issue 27(2016) Page Start: e3762 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial. Issue 27 (July 2016) Authors: Zhou, Jing; Zhao, Rongce; Wen, Feng; Zhang, Pengfei; Tang, Ruilei; Chen, Hongdou; Zhang, Jian; Li, Qiu Other Names: G Koniaris. Leonidas section editor. Journal: Medicine Issue: Volume 95:Issue 27(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild‐type metastatic colorectal cancer treated with first‐line epidermal growth factor receptor monoclonal antibody. Issue 10 (30th July 2013) Authors: Wen, Feng; Tang, Ruilei; Sang, Yaxiong; Li, Meng; Hu, Qiancheng; Du, Zedong; Zhou, Yi; Zhang, Pengfei; He, Xiaofeng; Li, Qiu Journal: Cancer science Issue: Volume 104:Issue 10(2013:Oct.) Page Start: 1330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗